Email
Hospital Circular 23/2011
Date Issued: 30 September 2011
Distribution: Public Hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals of changes to the Highly Specialised Drugs Program, effective 1 October 2011.
DELETED ITEMS
Ribavirin and Peginterferon Alfa-2b
9528L
Pack containing 84 capsules ribavirin 200mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 50 mcg with diluent
Pegatron
MK
9533R
Pack containing 84 capsules ribavirin 200mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 100 mcg with diluent
Pegatron
MK
9535W
Pack containing 84 capsules ribavirin 200mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 120 mcg with diluent
Pegatron
MK
9537Y
Pack containing 84 capsules ribavirin 200mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 mcg with diluent
Pegatron
MK
9532Q
Pack containing 168 capsules ribavirin 200mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 80 mcg with diluent
Pegatron
MK
Further information on the changes including the full restrictions can be found at www.health.vic.gov.au/hsdp or http://www.pbs.gov.au/browse/section100-hb
Maree Guyatt
Director
Integrated Care
Changes notified by hospital circular will be updated in the Guidelines on the Commonwealth/State Highly Specialised Drugs Program Guidelines website and the claim form amended.
